Scientists in Vermont have found something that shouldn’t exist: a cancer that swims. Living tumor cells moving from one brown bullhead catfish to another through the waters of Lake Memphremagog, crossing the invisible wall that normally keeps every cancer imprisoned inside the body that made it.

The discovery, published in Nature last week, makes this only the fourth known transmissible cancer in the entire animal kingdom — and the first ever found in a freshwater species. The others are the facial tumors devastating Tasmanian devils, a venereal tumor that’s been circulating among dogs for thousands of years, and leukemia-like cancers that hop between clams and mussels in the ocean. Each one represents a catastrophic failure of the basic biological contract: that your cells are yours, that a tumor is a private catastrophe, that cancer cannot be contagious.

The catfish were first noticed in 2012. Anglers and biologists kept seeing brown bullheads with raised black lesions — ugly growths that looked like pollution, or infection, or some environmental poison leaching from the nearby Coventry Landfill. By 2014, nearly a third of the fish in Lake Memphremagog had them. When researchers at the University of Vermont sequenced the tumor DNA, they expected to find a mutation that made individual fish susceptible — some genetic weakness, some local toxin. Instead they found that the cancer cells were more closely related to each other than to the fish carrying them. Hundreds of thousands of genetic variants shared across tumor samples, absent from every host.

That pattern is the signature of a clonal transmissible cancer: one original tumor, escaped from its first victim, now living as a parasite in the bodies of others.

What makes this one strange even among strange things is that it shouldn’t be possible. These are bottom-dwelling fish. They live in murky water, under rocks, in sediment. They don’t get sun exposure — the usual suspect for melanoma. They lack scales, which may matter: the researchers suspect transmission happens during spawning, when fish crowd together in shallow water, skin pressing against skin. Or perhaps tumor cells drift through sediment like microscopic seeds, waiting for another unscaled body to touch down.

The cancer has already left its home lake. Researchers found it in ponds and lakes across Vermont, New Hampshire, Maine, and New Brunswick — including waters with no pollution sources, no landfills, no obvious human cause. One possible clue: elevated arsenic levels inside the tumor cells themselves. Arsenic occurs naturally throughout New England soil. Whether it causes the cancer, weakens immune systems enough to let foreign cells take hold, or simply correlates with something else entirely, nobody knows yet.

There’s a passage in Thoreau’s journals from July 1852 — six years before Walden — where he describes a catfish on the Concord River with “a very large velvet-black spot.” He saw another in 1858, half its head covered in “an inky-black kind of leprosy, like a crustaceous lichen.” Researchers are now surveying Massachusetts waters to see if the same cancer has been there for a century and a half, hiding in plain sight, mistaken for disease or discoloration or the ordinary ugliness of wild things.

Julie Dragon, one of the study’s co-leaders, put it simply: “Our contention is that maybe it’s not as rare as everyone thinks. We’re just not seeing it because we aren’t looking for it.”

That sentence lands harder than she probably intended. We have spent decades mapping the human genome, sequencing tumors, hunting for cures — and all that time, a parallel form of cancer has been moving through the animal world, almost entirely invisible to us. The Tasmanian devil facial tumor wasn’t recognized as transmissible until 2006. The clam leukemia until 2015. The dog venereal tumor’s true nature wasn’t understood until genetic sequencing revealed it as an ancient cell lineage, possibly the oldest continuously living mammalian cells on Earth — a single cancer that has outlived millions of dogs across thousands of years.

Each discovery reframes what came before. Maybe transmissible cancers are not freak accidents but a persistent possibility, waiting for the right combination of biology and behavior and circumstance. Low genetic diversity in Tasmanian devils helped their facial tumor spread. Dogs’ ancient tumor thrives because it downregulates the immune markers that would flag it as foreign. The clam cancers move through filter-feeding water, a medium that carries cells as easily as it carries plankton. The catfish live scaleless, spawn in crowds, root through sediment where cells might linger.

The boundaries we draw between organisms — this body ends here, that one begins there — are more permeable than we like to believe. Cancer, that most private of diseases, has found ways to become public. And each time it does, it teaches us something about what normally keeps it contained. The immune system’s vigilance. Genetic diversity’s protection. The physical barriers of skin and scale and shell. When those fail, the tumor becomes something else: not a malfunction of one body, but a pathogen moving between bodies, evolving, adapting, surviving in ways that no ordinary cancer can.

The catfish melanoma is not a threat to humans. We cannot catch it. The fish are safe to handle. But it is a reminder that the categories we use — infectious vs. genetic, parasite vs. tumor, self vs. other — are human conveniences, not natural laws. Biology keeps finding edge cases that blur them. A cell that forgot which body it belonged to. A disease that learned to travel. A cancer that became, in its own terrible way, immortal.

I keep thinking about Thoreau’s catfish, lying on the river bottom in 1852, “evidently diseased,” permitting the boat to come within two feet. He didn’t know what he was looking at. None of us did, until last week. The question is how many other things we’re still not seeing — not because they’re hidden, but because we haven’t yet learned to ask the right questions.


Source: “Brown bullhead catfish melanoma represents a novel transmissible cancer”, Curd et al., Nature, July 22 2026. Additional reporting via SciTechDaily.